Transcendental Meditation in Veterans and First Responders With PTSD
Launched by RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC. · Dec 1, 2022
Trial Information
Current as of February 05, 2025
Active, not recruiting
Keywords
ClinConnect Summary
PTSD is among the most common and disabling problems for veterans and first responders. Although PTSD from combat-related events is widely known, veterans and first-responders also face traumatic experiences from other events including sexual trauma, accidents, and injuries. Recent findings, for example, indicated that nearly a quarter of female Veterans experienced sexual assault when in the military.
At present, the non-medication therapies for PTSD with the strongest scientific support include Prolonged Exposure (PE), Cognitive Processing Therapy (CPT), and Eye Movement Desensitization ...
Gender
ALL
Eligibility criteria
- General Inclusion Criteria:
- • 1. Prior or current military service OR prior or current work as a first responder (law enforcement, firefighters, and EMS)
- • 2. Active and primary diagnosis of PTSD with symptom duration ≥ 3 months
- • 3. CAPS-5 score ≥ 25 at intake assessment
- • 4. Age 18 - 80
- • 5. Able to give consent, English literate
- General Exclusion Criteria:
- • 1. Previous or current treatment with Transcendental Meditation, Present Centered Therapy, or any current psychotherapy.
- • 2. Current severe alcohol/cannabis use disorder or any other current substance use disorder except nicotine (i.e., nicotine use disorder and mild-moderate alcohol/cannabis use disorder are allowed)
- • 3. History of or present psychiatric diagnosis of psychotic episode, psychotic disorder, schizophrenia, schizoaffective disorder
- • 4. Current diagnosis of bipolar disorder
- • 5. Active suicidal or homicidal ideation or suicide attempt within two years of study enrollment
- • 6. Psychiatric hospitalization in the past six months
- • 7. Intent to change or begin new psychotherapy or other meditation therapy during 3-month study treatment
- • 8. Intent to enroll in another research study testing an experimental intervention during three-month period of study intervention
- • 9. Recent psychotropic medication dosage change or initiation within the three months prior to study enrollment
- • 10. Intent to change dosage of or initiate new psychotropic medication during the three-month period of study intervention
- • 11. Medical illness that could interfere with assessment of diagnosis, such as organic brain impairment or unstable thyroid disease
- • 12. Current unstable medical illness
- MRI Inclusion Criteria:
- • 1. Prior or current military service OR prior or current work as a first responder (law enforcement, firefighters, and/or EMS)
- • 2. Active and primary diagnosis of PTSD with symptom duration ≥ 3 months
- • 3. CAPS-5 score ≥ 25 at intake assessment
- • 4. Age 18 - 80
- • 5. Able to give consent, English literate
- • 6. Right handed
- MRI Exclusion Criteria:
- • 1. Previous or current treatment with Transcendental Meditation, Present Centered Therapy, or any current psychotherapy.
- • 2. Current severe alcohol/cannabis use disorder or any other current substance use disorder except nicotine (i.e., nicotine use disorder and mild-moderate alcohol/cannabis use disorder are allowed)
- • 3. History of or current psychiatric diagnosis of psychotic episode, psychotic disorder, schizophrenia, schizoaffective disorder
- • 4. Current diagnosis of bipolar disorder
- • 5. Active suicidal or homicidal ideation or suicide attempt within two years of study enrollment
- • 6. Psychiatric hospitalization in the past six months
- • 7. Intent to change or begin new psychotherapy or other meditation therapy during 3-month study intervention
- • 8. Intent to enroll in another research study testing an experimental intervention during three-month period of study intervention
- • 9. Recent psychotropic medication dosage change or initiation within the three months prior to study enrollment
- • 10. Intent to change dosage of or initiate new psychotropic medication during the three-month period of study intervention
- • 11. Paramagnetic metallic implants or devices contraindicating magnetic resonance imaging or any other non-removable paramagnetic metal in the body.
- • 12. Medical illness that could interfere with assessment of diagnosis, such as organic brain impairment or unstable thyroid disease
- • 13. Current unstable medical illness
- • 14. Any condition that would exclude clinical MRI exam (e.g. pacemaker, paramagnetic metallic prosthesis, surgical clips, shrapnel, necessity for constant medicinal patch, some tattoos)
- • 15. Significant claustrophobia that would preclude ability to remain calm within the MRI scanner
- • 16. Females who are pregnant or breastfeeding, or plan to become pregnant during the period of the study.
Trial Officials
Yuval Neria, PhD
Principal Investigator
NYSPI and Columbia University
About Research Foundation For Mental Hygiene, Inc.
The Research Foundation for Mental Hygiene, Inc. is a leading organization dedicated to advancing the understanding and treatment of mental health disorders through rigorous scientific research and clinical trials. Committed to improving public mental health outcomes, the foundation collaborates with academic institutions, healthcare providers, and community organizations to foster innovative research initiatives. By prioritizing evidence-based practices and promoting the dissemination of knowledge, the foundation aims to enhance the quality of care and support for individuals affected by mental health challenges, ultimately contributing to the broader goal of mental wellness in society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
New York, New York, United States
Palo Alto, California, United States
La Jolla, California, United States
Great Neck, New York, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials